These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 349524)

  • 1. [Aspirin in the prevention of thromboembolic diseases].
    Kuratowska Z
    Pol Arch Med Wewn; 1978 Jan; 59(1):53-9. PubMed ID: 349524
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?
    Bochner F; Lloyd J
    Clin Sci (Lond); 1986 Dec; 71(6):625-31. PubMed ID: 3098493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of low-dose aspirin on platelet aggregation and the biosynthesis of PGI2 and TXA2 in patients with coronary heart disease].
    Gao SW; Chen ZJ; Tao SQ
    Zhonghua Nei Ke Za Zhi; 1987 Apr; 26(4):209-12, 255. PubMed ID: 3308356
    [No Abstract]   [Full Text] [Related]  

  • 4. The enigma of aspirin.
    Parkin JD
    Aust N Z J Med; 1987 Apr; 17(2):192-4. PubMed ID: 3304245
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandins and aspirin-sensitive asthma.
    Szczeklik AJ; Gryglewski RJ
    Am Rev Respir Dis; 1978 Oct; 118(4):799-800. PubMed ID: 360898
    [No Abstract]   [Full Text] [Related]  

  • 6. Eicosanoids and venous thromboembolism.
    Fitzpatrick JW; Giudice JC; Papa L; Freed N
    J Am Osteopath Assoc; 1983 Dec; 83(4):301-6. PubMed ID: 6365860
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of functional activity of thrombocytes in patients with "aspirin" bronchial asthma].
    Evsiukova EV
    Klin Med (Mosk); 1991 Sep; 69(9):26-9. PubMed ID: 1803142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of non-steroidal anti-inflammatory drugs on the in vivo synthesis of thromboxane and prostacyclin in humans.
    Drvota V; Vesterqvist O; Gréen K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():153-6. PubMed ID: 1825533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylsalicylic acid in the prevention and therapy of thrombotic diseases. Theoretical findings and prospects].
    Weber E
    Med Welt; 1975 Aug; 6(35):1493-8. PubMed ID: 1177739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylsalicylic acid in the prevention and therapy of thromboembolic diseases. Principles of practical use].
    Breddin K
    Med Welt; 1975 Aug; 6(35):1499-502. PubMed ID: 1237073
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin resistance: what, why and when?
    Shantsila E; Watson T; Lip GY
    Thromb Res; 2007; 119(5):551-4. PubMed ID: 17010411
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
    Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
    Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.
    Hirsh J
    Stroke; 1985; 16(1):1-4. PubMed ID: 3880945
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
    Lumley P; Keery RJ; Wharton KA; White BP; Watts IS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():603-6. PubMed ID: 1825385
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin as an antithrombotic medication.
    Marcus AJ
    N Engl J Med; 1983 Dec; 309(24):1515-7. PubMed ID: 6358887
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
    Hirsh J; Salzman EW; Harker L; Fuster V; Dalen JE; Cairns JA; Collins R
    Chest; 1989 Feb; 95(2 Suppl):12S-18S. PubMed ID: 2644095
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins and platelets.
    Mustard JF; Kinlough-Rathbone RL; Packham MA
    Annu Rev Med; 1980; 31():89-96. PubMed ID: 6994628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.